Dana Investment Advisors Inc. Acquires Shares of 23,925 OR Royalties Inc. $OR

Dana Investment Advisors Inc. acquired a new stake in OR Royalties Inc. (NYSE:OR) in the fourth quarter, HoldingsChannel reports. The institutional investor acquired 23,925 shares of the basic materials company’s stock, valued at approximately $847,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Assetmark Inc. purchased a new position in OR Royalties in the 4th quarter valued at about $36,000. Caitlin John LLC acquired a new stake in shares of OR Royalties in the 3rd quarter valued at about $78,000. Allworth Financial LP raised its stake in shares of OR Royalties by 20.0% in the 4th quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock valued at $82,000 after purchasing an additional 384 shares in the last quarter. Merit Financial Group LLC acquired a new stake in shares of OR Royalties in the 3rd quarter valued at about $215,000. Finally, Flow Traders U.S. LLC acquired a new stake in shares of OR Royalties in the 3rd quarter valued at about $217,000. 68.52% of the stock is owned by hedge funds and other institutional investors.

OR Royalties Stock Performance

OR Royalties stock opened at $36.17 on Tuesday. The company has a 50 day moving average price of $38.85 and a 200 day moving average price of $38.36. OR Royalties Inc. has a 52 week low of $23.37 and a 52 week high of $48.06. The firm has a market capitalization of $6.78 billion, a price-to-earnings ratio of 26.99 and a beta of 0.71.

OR Royalties (NYSE:OR) last posted its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.06. OR Royalties had a net margin of 78.09% and a return on equity of 15.10%. The firm had revenue of $102.83 million during the quarter, compared to analyst estimates of $103.27 million. Equities analysts forecast that OR Royalties Inc. will post 1.4 earnings per share for the current fiscal year.

OR Royalties Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Tuesday, June 30th will be paid a $0.065 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $0.26 dividend on an annualized basis and a yield of 0.7%. This is a positive change from OR Royalties’s previous quarterly dividend of $0.06. OR Royalties’s dividend payout ratio (DPR) is 16.42%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on OR. Scotiabank upped their target price on shares of OR Royalties from $41.00 to $51.00 and gave the company a “sector perform” rating in a research note on Monday, January 26th. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of OR Royalties in a research note on Wednesday, February 4th. Zacks Research lowered shares of OR Royalties from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. TD Securities restated a “hold” rating on shares of OR Royalties in a research note on Monday, February 23rd. Finally, Wall Street Zen lowered shares of OR Royalties from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $46.50.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.